Moderna, Inc.
MRNANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $79.64B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $22.28$243.98
- Volume (live)
- -
- Avg. volume (3M)
- 18.58M
Moderna (MRNA) Stock Price & Financial Analysis
Moderna Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $183.00 - $206.97 |
|---|---|
| 52-Week High | $243.98 |
| 52-Week Low | $22.28 |
| Open | $196.69 |
| Volume (last close) | 21.57M |
| Average Volume (3M) | 18.58M |
| Revenue (TTM) | 2.23B |
|---|---|
| Net Income (TTM) | -3.15B |
| Free Cash Flow (TTM) | -1.22B |
| EPS (TTM) | −$8.00 |
| Profit Margin | -141.43% |
| Operating Margin | -149.01% |
| Return on Equity (ROE) | -46.61% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 79.64B |
|---|---|
| Shares Outstanding | 398.00M |
| Price to Sales (P/S) | 35.74 |
| Price to Book (P/B) | 11.78 |
| EV/EBITDA | -27.03 |
| 50-Day MA | $161.93 |
|---|---|
| 200-Day MA | $79.44 |
| 1-Year Change | +671.92% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Moderna at a Glance
As of the Oct 23, 2026 close, Moderna (MRNA) has a market capitalization of $79.64B. The stock trades at 35.7× sales. Over the trailing twelve months it lost $3.15B on revenue of $2.23B and burned $1.22B of free cash flow. Revenue fell 27.1% year over year.
As of its latest reported balance sheet, it holds $1.72B in cash and securities against $643.00M of debt, a net cash position of $1.08B.
Moderna does not currently pay a dividend.
The share price is up 671.9% over the past year. At $200.10 (the Oct 23, 2026 close) it sits within its 52-week range of $22.28 to $243.98, above its 200-day moving average of $79.44.
Based on 25 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $113.75, 43.2% below the Oct 23, 2026 close.
Frequently Asked Questions About Moderna
What is the current stock price for MRNA?
As of the Oct 23, 2026 close, MRNA stock trades at $200.10. The 52-week range is $22.28–$243.98, with a day range of $183.00–$206.97.
What is the P/E ratio for MRNA?
The P/E ratio (Price-to-Earnings) for MRNA is shown in the Key Statistics section. This valuation metric helps compare Moderna, Inc. to industry peers.
Does MRNA pay dividends?
Moderna does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MRNA?
Based on ratings from 25 professional analysts over the last 90 days, the consensus for MRNA is Hold. The average 12-month price target is $113.75, a 43.2% downside from the Oct 23, 2026 close of $200.10.
What is the market cap of MRNA?
As of the Oct 23, 2026 close, Moderna's market capitalization is $79.64B, classifying it as a large-cap company. Moderna operates in the Healthcare sector within the Biotechnology industry.